Summary We examined the cytotoxicity and biochemical effects of the lipophilic antifol trimetrexate (TMQ) in two human colon carcinoma cell lines, SNU-C4 and NCI-H630, with different inherent sensitivity to TMQ. While a 24 h exposure to 0.1 M TMQ inhibited cell growth by 50-60% in both cell lines, it did not reduce clonogenic survival. A 24 h exposure to 1 and 10 ILM TMQ produced 42% and 50% lethality in C4 cells, but did not affect H630 cells. Dihydrofolate reductase (DHFR) and thymidylate synthase were quantitatively and qualitatively similar in both lines. During drug exposure, DHFR catalytic activity was inhibited by > 85% in both cell lines; in addition, the reduction in apparent free DHFR binding capacity (,<20% of control), depletion of dTTP, ATP and GTP pools and inhibition of [6-3H]deoxyuridine incorporation into DNA were similar in C4 and H630 cells. TMQ produced a more striking alteration of the pH step alkaline elution profile of newly synthesised DNA in C4 cells compared with 630 cells, however, indicating greater interference with DNA chain elongation or more extensive DNA damage. When TMQ was removed after a 24 h exposure to 0.1 tM, recovery of DHFR catalytic activity and apparent free DHFR binding sites was evident over the next 24 -48 h in both cell lines. With 1 and 10 JAM, however, persistent inhibition of DHFR was evident in C4 cells, whereas DHFR recovered in H630 cells. These data suggest that, although DHFR inhibition during TMQ exposure produced growth inhibition, DHFR catalytic activity 48 h after drug removal was a more accurate predictor of lethality in these two cell lines. Several factors appeared to influence the duration of DHFR inhibition after drug removal, including initial TMQ concentration, declining cytosolic TMQ levels after drug removal, the ability to acutely increase total DHFR content and the extent of TMQ-mediated DNA damage. The greater sensitivity of C4 cells to TMQ-associated lethality may be attributed to the greater extent of TMQ-mediated DNA damage and more prolonged duration of DHFR inhibition after drug exposure.
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Methotrexate, a 'classical' antifol, has been useful in the treatment of human neoplasms including acute lymphocytic leukaemia, non-Hodgkin's lymphoma, osteosarcoma, breast cancer and squamous cell carcinoma of the head and neck. Methotrexate is clinically inactive, however, against several human solid tumours, including colorectal carcinoma. Resistance to methotrexate has been attributed to numerous mechanisms , including impaired membrane transport (Assaraf & Schimke, 1987; Schuetz et al., 1988) , defective polyglutamation (Cowan & Jolivet, 1984; Pizzorno et al., 1988) , reduced affinity of the target enzyme dihydrofolate reductase (EC 1.5.1.3, DHFR) (Jackson et al., 1980; Melera et al., 1987) , increase in total DHFR activity due to gene amplification (Kaufman & Schimke, 1981; Cowan et al., 1982; Domin et al., 1983) , decreased levels of thymidylate synthase (EC 2.1.1.45, TS) (White & Goldman, 1981; and thymidine (dThd) salvage (Van Mouwerik et al., 1987) .
'Non-classical' antifols have been developed in an effort to overcome potential mechanisms of resistance. Trimetrexate (TMQ) is a 2,4-diaminoquinazoline antifol that is undergoing clinical evaluation as an antineoplastic agent and has been approved for the treatment of AIDS-related Pneumocystis carinii infection. Unlike methotrexate, TMQ is lipophilic and enters the cell by a transport process distinct from the reduced folate carrier (Diddens et al., 1983; Jackson et al., 1984; Kamen et al., 1984) . TMQ is a direct, potent inhibitor of DHFR, and does not undergo polyglutamation. In preclinical models, TMQ is active against several murine solid tumours which are refractory to methotrexate (Lin & Bertino, 1987) . Cells which are resistant to methotrexate on the basis of impaired membrane transport are sensitive to TMQ (Mini et al., 1985; Van Der Veer et al., 1989) . Multidrugresistant (MDR) cell lines are cross-resistant to TMQ; verapamil enhances TMQ cytotoxicity in these cells (Klohs et al., 1986; Assaraf et al., 1989 (Grem & Fischer, 1985; Grem & Allegra, 1990 (Drake et al., 1985) . Aliquots of the effluent were counted, permitting measurement of the loss of bound [3H]methotrexate from DHFR over time.
Thymidylate synthase activity and binding TS activity in an aliquot of cytosol was assayed by a modification of a [5-3H]dUMP release assay (Yalowich & Kalman, 1985; Roberts, 1966) . dUMP pools were determined with the same assay except that excess exogenous TS and reduced folate were added, and the amount of dUMP was the limiting substrate (Grem et al., 1989) . The formation of a ternary complex consisting of TS, 5,10-methylene tetrahydrofolate and [6-3H]5-FdUMP was studied using a binding assay (Moran et al., 1979; Allegra et al., 1986 ).
Measurement of deoxy-and ribonucleotide triphosphate pools dTTP pools were monitored using a previously described enzymatic assay (Grem & Fischer, 1985) . ATP and GTP pools were determined by anion-exchange HPLC as previously described (Grem & Allegra, 1990 ).
Intracellular folate pool measurements
Exponentially growing cells in folate-free medium supplemented with 0.1 LM d,l-leucovorin were exposed to [3H]-leucovorin for a 72 h period, following which the cells were washed twice with PBS. Fresh medium was replaced, and then TMQ (1 gM) or dH2O was added for a 24 h period. The cells were either harvested immediately or washed twice with PBS and incubated in drug-free medium for an additional 24 h period. Folates were extracted, enzymatically hydrolysed to monoglutamate forms, then separated and quantitated by reversed-phase HPLC as previously described (McMartin et al., 1981; Allegra et al., 1986; Baram et al., 1987) .
pH step alkaline elution of nascent DNA Exponentially growing cells were exposed to either no drug or 1 and 10 tAM TMQ for 24 h; [3H]dThd (10 fACi) was added during the final 2 h of exposure. The cells were then washed three times with ice-cold PBS, and the cells were detached by incubation with 20 mM disodium EDTA (pH 7.0). An equal number of cells was deposited on Nucleopore filters (25 mm, 1 lm pore size; Costar, Cambridge, MA, USA), held in an alkaline elution funnel (Millipore), then lysed in the dark with 5 ml of buffer containing 2 M sodium chloride, 0.3% sarcosyl detergent (pH 7.0) and 20 mM dosodium EDTA, pH 10.0 (Erickson et al., 1979; Ross et al., 1990) . The lysed cells were washed with 5 ml of 20 mM disodium EDTA (pH 10) and then the exit tubing from the filter funnel was connected to a peristaltic pump (Minipuls III; Gilson Instrument, Middleton, WI, USA). A solution containing 20 mM EDTA (free acid form) adjusted to pH 11.3 with 1 M tetrapropylammoniumhydroxide (RSA, Ardsley, NY, USA) was added to the funnel and pumped through the filter at a rate of 0.08 ml min-'. After 1 h, the solution was changed to one at pH 11.5, and the elution was continued for another hour. Fractions were collected with an automated fraction collector. This procedure was repeated for successive elutions at pH 11.7 and 12.1. The filter and elution fractions were neutralised with 150 p1 of glacial acetic acid; scintillation fluid was added, and after a 24 h equilibration period the radioactivity was determined. The data were corrected for background counts.
Cell cycle analysis The method of Krishan (1975) was used to evaluate the fraction of cells in each DNA cycle. Briefly, exponentially growing cells were exposed to no drug or to 1 liM TMQ for 24 h, then were lysed in a hypotonic solution in dilute citric acid. The nuclei were isolated, treated with DNAse-free RNAse, stained with propidium iodide, and then passed through a 35 tLm nylon mesh. The cells were analysed on a 
Results

Comparison of TMQ-induced lethality
The doubling times during log-phase growth were similar: 18 h (C4 cells) and 22 h (H630 cells). After a 24 h exposure to TMQ followed by a 48 h drug-free period, the IC50 values for growth inhibition were 0.05 (C4) and 0.1ILM (H630), respectively. A 24 h exposure to 0.1ILM TMQ, however, decreased colony formation by only 20% in C4 cells and had minimal effect in H630 cells (Figure 1) . A 24 h exposure to 1I1AM and 1OIM TMQ reduced cell growth by 78% ±4% and 84% ± 3% of control in C4 cells, and clonogenic capacity was decreased by 42% and 50% respectively. In (500) were replicately plated in six-well plates. The next day, varying concentrations of TMQ were added. Following a 24 h exposure, the cells were gently washed twice and fresh drug-free medium was replaced. Six days later, the cells were stained with methylene blue (0.25%) in 50% methanol, and colonies were enumerated. The data, presented as the mean ± s.e.m. are from >4 separate experiments each done in duplicate: V, C4; *, H630. The cloning efficiency of control cells was as follows: C4, 51% ± 5%; H630, 31% ± 2%. Similar results were obtained if a 2 day equilibrium period was allowed between plating and initial drug exposure.
H630 cells, a 24 h exposure to 1 and 1O lM TMQ reduced cell growth by 66% ± 6% and 72% ± 4% respectively, whereas colony formation was minimally affected. Concur- reached a plateau by 30 min, at which time the levels of cell-associated TMQ were similar in both lines (mean ± range: n = 2): C4, 30 ± 2 pmol 10-6 cells; H630, 32 ± 9 pmol 10-6 cells.
Because of the possibility that differences in TMQ accumulation might occur following a more prolonged exposure, ['4C]TMQ retention was also determined following a 24 h exposure (1 tM) in complete medium. Immediately after drug removal, cytosolic TMQ was 2.5-fold higher in C4 than in H630 cells (mean ± s.e.m. n = 8): 149 ± 8 vs 60 ± 4 pmol mg-' protein (P<0.001, paired t-test). TMQ levels decreased over the next 24 h in both cell lines, but remained 1.6-fold higher in C4 cells: 13.4± 1.4 vs 8.6±0.7pmolmg-' (P = 0.003). TMQ levels decreased only slightly thereafter (72 h, 9.2 + 1.7 vs 8.5 ± 0.8 pmol mg-'). Differences in TMQ retention after a 24 h exposure might therefore contribute to the disparity in sensitivity between the C4 and H630 cells.
Activity of dihydrofolate reductase and thymidylate synthase The characteristics of DHFR in cell-free assays from nondrug treated cells are shown in Table I Effect of TMQ exposure on total DHFR content To test the hypothesis that total DHFR content may change following a 24 h TMQ exposure, cytosol obtained from control and drug-treated cells was extensively dialysed to remove free TMQ and drug bound to DHFR. A longer (3 h) incubation with [3H]methotrexate was also used to permit complete exchange with any residual bound TMQ. The adequacy of dialysis was assessed by comparing the DHFR binding capacity of cells harvested immediately after 1 h exposure to TMQ with control values. We reasoned that a 1 h exposure would be too brief to result in changes in total levels of DHFR; therefore, if DHFR levels measured after a 1 h drug exposure were similar to control levels, the dialysis was assumed to be complete. After a 24 h and 48 h period of dialysis, the DHFR binding capacity in cytosols from cells exposed for 1 h to 0.1 and 1.0 JiM TMQ, respectively, was 1.2-fold (± 0.1) of control values in both cell lines, indicating that essentially all TMQ had been removed from DHFR. Immediately after a 24 h exposure to 0.1IJM TMQ, however, an increase in total DHFR binding over baseline was evident in both lines (pmol mg-'): C4, 3.3 ± 0.6 (n = 6) vs 1.7 0.2 (n = 16, P= 0.004); H630, 3.1 ± 0.4 (n = 9) vs 0.9 0.1 (n = 14, P<0.001). With 1 JAM TMQ, no increase in DHFR binding capacity was seen in C4 cells (1.8 ± 0.3 pmol mg-', n = 8). A 2.2-fold increase over baseline DHFR binding occurred, however, in H630 cells: 2.0 ± 0.2 pmol mg-' (n = 6, P>0.001). With 10 JAM TMQ, removal of bound drug was incomplete after 72 h of dialysis. Prolonged dialysis beyond 72 h resulted in progressive loss of enzymatic activity; therefore, experiments using higher concentrations could not be reliably interpreted using the binding assay.
Because DHFR content may vary in different phases of the cell cycle, it was important to ascertain the effect of TMQ on cell cycle distribution. The proportion of control cells in S-phase was similar in both cell lines (C4, 45% ± 17%; H630 cells, 48% ± 14%, mean ± s.d., n = 3). A 24 h exposure to 1 JAM TMQ was associated with an 11-12% increase in the proportion of cells in S-phase in both cell lines (C4, 56% ± 36%; H630, 60% ± 24%). No change was seen in the proportion of cells in Go/G1. TMQ exposure was accompanied by a block in the entry of cells into G2/M phase (control vs TMQ-treated, mean ± s.d.): C4, 11% ± 2% vs 0.7% ± 0.7%; H630, 12% ± 1% vs 0.6% ± 0.1%. Thus, 1 JM TMQ produced comparable effects on the cell cycle in each cell line.
An increase in DHFR protein levels was confirmed by Western immunoblot analysis in H630 cells treated with 1 JiM TMQ for 24 h (Figure 5 ), whereas no appreciable change was evident in C4 cells. To determine whether new protein synthesis contributed to this phenomenon, the effect of a 24 h exposure to cycloheximide (CHEX) on [35S]methionine incorporation into acid-precipitable material was determined. Then, the effect of concurrent exposure to CHEX and TMQ was investigated. A 24 h exposure to CHEX with 1 JiM TMQ attenuated the TMQ-associated increase in DHFR content in a dose-dependent fashion (fold increase in DHFR densitometry signal relative to control): TMQ alone, 2.5-fold; TMQ + 5 JAM CHEX (which inhibited protein synthesis by 40%), 1.7-fold; TMQ + 50 JAM CHEX (which inhibited protein synthesis by 79%), 1.2-fold. DHFR content in H630 cells remained 2.4-to 2.8-fold higher relative to control for up to 48 h after removal of 1 tLM TMQ (data not shown).
Effect of TMQ on dTTP and RTP pools
The magnitude of dTTP depletion following antifol treatment might be influenced by the degree of TS inhibition and the contribution of dThd salvage. Following a 24 h exposure to 1.0 iM TMQ, dTTP pools were similarly decreased to 26% and 17% of control in each line (Table IV) . More pronounced dTTP depletion (, 10% of control) was seen with 10 pM TMQ in both lines. Dose-dependent decreases in ATP and GTP pools were evident in both cell lines after a 24 h drug exposure (Table IV) . The magnitude of the effect was similar in both cell lines. The ability of intact cells to salvage dThd and purines was then ascertained by measuring nucleotide formation (by HPLC analysis of methanol-soluble cell extracts) and macromolecular incorporation (methanol-precipitable fraction) after a 1 h incubation with 1 JiM [3H]dThd or [3H]hypoxanthine. dThd salvage (pmol 10-6 cells h-') was 45.4 ± 1.4 in H630 cells (mean + s.d., n = 3), and was 1.9-fold higher in C4 cells: 86.7 ± 0.9. Hypoxanthine salvage (pmol 10-6 cells h-') was 1,695 ± 65 in H630 cells, and 1,168 ± 55 in C4 cells. These data indicate that both cell lines were capable of salvaging preformed dThd and purine bases.
Effect of TMQ on nascent DNA synthesis pH step alkaline elution was used to assess the effect of TMQ on newly synthesised DNA. In the pH transition zone, molecular weight influences the selective denaturation of newly replicated DNA exposed to alkali (Erickson et al., 1979; Ross et al., 1990) . Therefore, stepwise elution of DNA with an alkaline solution at pH values ranging from 11.3 to 12.1 may show relative differences in the single strand length of newly synthesised DNA. The proportion of single-strand DNA species eluting with the 11.3-11.7 fractions in control C4 and H630 cells was similar (about 7%), as was the proportion of high molecular weight DNA retained on the polycarbonate filter (about 50%, Figure 6) . A 24 h exposure to TMQ altered the elution profile in both cell lines: an accumulation of lower molecular weight DNA species was noted, accompanied by a decreased proportion of DNA retained on the filter. These results suggest either interference with DNA chain elongation during drug exposure or induction of DNA single-strand breaks associated with substrate (dTTP) depletion and/or excision of deoxyuridine triphosphate by DNA repair enzymes. The abnormalities were more striking in C4 cells: 47-54% of the DNA eluted with or before the pH 11.7 solution in cells exposed to 1 and 10 jiM I gM TMQ 33 ± 13* (26%) 9 ± 6 (45%) 0.8 ± 0.5* (24%) 10pM TMQ 13±4* (10%) 7 1* (34%) 0.6±0.1* (18%)
Exponentially growing cells were exposed to either no drug, 1.0 iLM TMQ or 1O jiM TMQ for 24 h. The cells were then extracted with 0.5 N PCA, neutralized and then lyophilised. TMQ, compared with 19-26% in H630 cells; further, only 10% of the DNA was retained on the filter in C4 cells compared to 22-26% in H630 cells. These data indicate that the extent of damage and/or interference with elongation of newly synthesised DNA was greater in the more sensitive C4 cell line.
Discussion
We found a disparity between sensitivity to TMQ-associated lethality in two human colon cancer cell lines which had not been selected for antifol resistance. Previously described mechanisms of antifol resistance did not appear to account for the relative insensitivity of H630 cells. DHFR and TS in non-drug-treated cells were quantitatively and qualitatively similar in both cell lines. TMQ does not require the reduced folate transport mechanism for cell uptake, nor does it undergo polyglutamation. Some cancer cells expressing the MDR phenotype are cross-resistant to TMQ; decreased accumulation of TMQ has been noted during brief (1-2 h) incubations (Klohs et al., 1986; Assaraf et al., 1989) . Verapamil increased TMQ cytotoxicity in these MDR cells. Single-step selection of mammalian cells with TMQ revealed that the majority of the clonal variants displayed crossresistance to other lipophilic antifols; although this resistance was not related to the MDR phenotype, decreased TMQ accumulation was evident and low concentrations of verapamil potentiated TMQ cytotoxicity (Sharma et al., 1991) . These mechanisms would not seem to apply to H630 cells, since verapamil did not enhance TMQ toxicity. The capacity Fry and Besserer (1988) previously reported both an intracellular exchangeable pool of TMQ that was always several-fold higher than the extracellular concentration and a large non-exchangeable fraction of TMQ after drug removal that exceeded the DHFR-binding capacity in human lymphoblastoid cells. Decreased accumulation or retention of lipophilic antifols might conceivably result from changes in TMQ binding to proteins other than DHFR or to other macromolecules by a process that is unaffected by verapamil (Assaraf & Slotky, 1993) .
H630 cells have the ability to increase thymidylate synthase protein synthesis during fluorouracil exposure, which permits recovery of TS catalytic activity (Chu et al., 1993) . Abrogation of the increase in thymidylate synthase content by interferon y enhanced sensitivity to fluorouracil (Chu et al., 1990) . Swain et al. (1989) (Domin et al., 1982; Bastow et al., 1984; Cowan et al., 1986; Bertino et al., 1962 Bertino et al., , 1963 . The apparent basis for the increase in DHFR content has varied depending on the cell line or model system used. The experimental evidence suggests multiple possible mechanisms including stabilisation of DHFR by methotrexate accompanied by an increased intracellular half-life, and methotrexate-dependent alterations in DHFR content at both the transcriptional and post-transcriptional or translational level. Chu et al. (1993) have recently reported that, in a cell-free system, DHFR protein specifically binds to DHFR mRNA and inhibits translation; the addition of methotrexate prevented the binding of DHFR protein to its mRNA, allowing translation to proceed. Thus, DHFR appears to be capable of translational autoregulation in a cell-free system. In intact cells, the factors governing regulation of DHFR expression are undoubtedly more complex. In a methotrexate-resistant subline of human KB cells which have a stable 40-fold amplification of DHFR, Domin et al., (1982) reported that an additional increase (up to 4-fold) in DHFR content occurred after a 48 h exposure to various concentrations of methotrexate. A growth-inhibitory but non-lethal TMQ exposure (0.1 JIM x 24 h) was accompanied by a 1.9-and 3.4-fold increase in total DHFR in C4 In summary, the relative insensitivity to TMQ-mediated lethality in H630 cells compared with C4 cells appears to be related to greater recovery of DHFR activity after drug removal. Recovery of functional DHFR may result from several factors, including less DNA damage, reduced cytosolic TMQ levels after a 24 h exposure and an increase in total DHFR content. The underlying basis for the difference in DNA damage during drug exposure in C4 and H630 cells will require additional study. Finally, our data suggest that prolonged exposure to TMQ may represent a potential strategy to increase its cytotoxicity. Preliminary data from our laboratory suggests that extending the duration of TMQ exposure to 72 h increases the sensitivity of H630 cells to TMQ. Further investigation will be required to characterise more fully the effect of TMQ and other antifols on DHFR content in H630 cells and other cell lines, and to elucidate the factors governing regulation of DHFR expression. 
